Hematology Analyzers & Reagents Market Research Report by Price Range (High-End Hematology Analyzers, Low-End Hematology Analyzers, and Mid-Range Hematology Analyzers), by Product & Service (Hematology Products & Services, Hemostasis Products & Services,

Hematology Analyzers & Reagents Market Research Report by Price Range (High-End Hematology Analyzers, Low-End Hematology Analyzers, and Mid-Range Hematology Analyzers), by Product & Service (Hematology Products & Services, Hemostasis Products & Services, and Immunohematology Products & Services), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

The Global Hematology Analyzers & Reagents Market is expected to grow from USD 4,102.29 Million/EUR 3,596.97 Million in 2020 to USD 6,131.99 Million/EUR 5,376.64 by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.37%.

Market Segmentation & Coverage:

This research report categorizes the Hematology Analyzers & Reagents to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Price Range, the Hematology Analyzers & Reagents Market studied across High-End Hematology Analyzers, Low-End Hematology Analyzers, and Mid-Range Hematology Analyzers.

Based on Product & Service, the Hematology Analyzers & Reagents Market studied across Hematology Products & Services, Hemostasis Products & Services, and Immunohematology Products & Services. The Hematology Products & Services further studied across Instruments, Reagents & Consumables, and Services. The Hemostasis Products & Services further studied across Instruments, Reagents & Consumables, and Services. The Immunohematology Products & Services further studied across Instruments, Reagents & Consumables, and Services.

Based on End User, the Hematology Analyzers & Reagents Market studied across Commercial Service Providers, Government Reference Laboratories, Hospital Laboratories, and Research and Academic Institutes.

Based on Geography, the Hematology Analyzers & Reagents Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Hematology Analyzers & Reagents Market including Abbott Laboratories, Bio-Rad Laboratories, Inc., Biosystems S.A., Boule Diagnostics AB, Danaher Corporation, Diatron, Drew Scientific Inc, EKF Diagnostics, F. Hoffmann-La Roche Ltd, Horiba, Ltd., Mindray Medical International Limited, Nihon Kohden Corporation, Ortho-Clinical Diagnostics Inc, Siemens Healthcare GmbH, and Sysmex Corporation.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hematology Analyzers & Reagents Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Hematology Analyzers & Reagents Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hematology Analyzers & Reagents Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hematology Analyzers & Reagents Market?
4. What is the competitive strategic window for opportunities in the Global Hematology Analyzers & Reagents Market?
5. What are the technology trends and regulatory frameworks in the Global Hematology Analyzers & Reagents Market?
6. What are the modes and strategic moves considered suitable for entering the Global Hematology Analyzers & Reagents Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product & Service Outlook
3.4. Price Range Outlook
3.5. End User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
4.3. Geographic Growth Opportunities
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing blood donation
5.1.1.2. Rising incidence of blood disorders
5.1.1.3. Technological advancements
5.1.1.4. Integration of hematology analyzer with flow cytometry
5.1.2. Restraints
5.1.2.1. Product recalls and safety alerts
5.1.2.2. Slow adoption of advanced hematology instruments in emerging countries
5.1.3. Opportunities
5.1.3.1. Growing opportunities with the use of automated hematology analyzers
5.1.3.2. Market penetration opportunities in emerging countries
5.1.3.3. Rising awareness among end-users about advanced hematology analyzers
5.1.3.4. Emergence of microfluidics technology
5.1.4. Challenges
5.1.4.1. High cost of advanced hematology analyzers
5.1.4.2. Stringent and time-consuming regulatory processes significantly increasing the gestation period for product launches
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. Global Hematology Analyzers & Reagents Market, By Price Range
6.1. Introduction
6.2. High-End Hematology Analyzers
6.3. Low-End Hematology Analyzers
6.4. Mid-Range Hematology Analyzers
7. Global Hematology Analyzers & Reagents Market, By Product & Service
7.1. Introduction
7.2. Hematology Products & Services
7.2.1. Instruments
7.2.1.1. 5-Part and 6-Part Fully Automated Hematology Analyzers
7.2.1.2. Part Fully Automated Hematology Analyzers
7.2.1.3. Point-Of-Care Testing Hematology Analyzers
7.2.1.4. Semi-Automated Hematology Analyzers
7.2.2. Reagents & Consumables
7.2.2.1. Consumables
7.2.2.2. Controls and Calibrators
7.2.2.3. Hematology Reagents
7.2.2.4. Slide Stainers/Makers
7.2.3. Services
7.3. Hemostasis Products & Services
7.3.1. Instruments
7.3.2. Reagents & Consumables
7.3.3. Services
7.4. Immunohematology Products & Services
7.4.1. Instruments
7.4.2. Reagents & Consumables
7.4.3. Services
8. Global Hematology Analyzers & Reagents Market, By End User
8.1. Introduction
8.2. Commercial Service Providers
8.3. Government Reference Laboratories
8.4. Hospital Laboratories
8.5. Research and Academic Institutes
9. Americas Hematology Analyzers & Reagents Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Hematology Analyzers & Reagents Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. Europe, Middle East & Africa Hematology Analyzers & Reagents Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. Bio-Rad Laboratories, Inc.
13.3. Biosystems S.A.
13.4. Boule Diagnostics AB
13.5. Danaher Corporation
13.6. Diatron
13.7. Drew Scientific Inc
13.8. EKF Diagnostics
13.9. F. Hoffmann-La Roche Ltd
13.10. Horiba, Ltd.
13.11. Mindray Medical International Limited
13.12. Nihon Kohden Corporation
13.13. Ortho-Clinical Diagnostics Inc
13.14. Siemens Healthcare GmbH
13.15. Sysmex Corporation
14. Appendix
14.1. Discussion Guide

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook